LAVIPHARM S.A. NA EO 1 (BXA0) — Cash Flow Reinvestment Rate
LAVIPHARM S.A. NA EO 1 (BXA0) has a Cash Flow Reinvestment Rate of 2.08x as of December 2024, reinvesting €9.64 Million (capex €9.64 Million ) from operating cash flow of €4.64 Million. Explore BXA0 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
LAVIPHARM S.A. NA EO 1 Cash Flow Reinvestment Rate (2021–2024)
Historical reinvestment intensity for LAVIPHARM S.A. NA EO 1 across 4 annual periods. Also explore LAVIPHARM S.A. NA EO 1 balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for LAVIPHARM S.A. NA EO 1 (2021–2024)
Year-by-year capital reinvestment analysis for LAVIPHARM S.A. NA EO 1. For live market cap and broader valuation context, see market value of LAVIPHARM S.A. NA EO 1.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.08x | €9.64 Million | €4.64 Million | €9.64 Million | ▼ -85.4% |
| 2023 | 14.26x | €4.05 Million | €284.00K | €4.05 Million | ▲ +33.9% |
| 2022 | 10.64x | €35.62 Million | €3.35 Million | €35.62 Million | ▲ +2181.6% |
| 2021 | 0.47x | €1.92 Million | €4.11 Million | €1.92 Million | — |